Sign-in Help
Home / Life Sciences / Key developments and materials / Weekly highlights

Legal News

Life Sciences weekly highlights—26 April 2018

Life Sciences weekly highlights—26 April 2018
Published on: 26 April 2018
Published by: LexisPSL
  • Life Sciences weekly highlights—26 April 2018
  • In this issue:
  • Brexit
  • Important relocation decision for EMA
  • MHRA sets out five-year strategy
  • Research and development
  • Government lacks ‘ambitious’ plan for increasing R&D investment
  • Calls for renewal of Concordat and Moratorium, as NHS genomics capabilities being ‘held back’
  • Manufacture, marketing and sale
  • Pharmacy (Premises Standards, Information Obligations, etc) Order 2016 (Commencement) (England, Wales and Scotland) Order of Council 2018
    • More...

Article summary

This week’s edition of Life Sciences highlights includes an update on the relocation of the EMA, information about the MHRA’s corporate plan for 2018–2023, the MHRA’s guidance for safely purchasing medical devices for personal use and analysis on the significance of the data protection provisions in the draft Brexit withdrawal agreement. or take a trial to read the full analysis.

Popular documents

LEXISNEXIS

The pari passu principle and collection remedies for the office-holder—the position under the Insolvency (England and Wales) Rules 2016

The primary function of office-holders in personal and corporate insolvency is to collect in the assets belonging to a company or individual and to distribute these to the company's or individual's creditors. Office-holders have various duties and powers in order to ensure that they do this. For

LEXISNEXIS

Third party rights—the common law doctrine of privity of contract

This Practice Note discusses the common law doctrine of privity of contract; the equitable and statutory exceptions to it; how the doctrine affects enforcing a contract against a third party and what happens when, notwithstanding the lack of privity, a contract has an indirect effect on a third

LEXISNEXIS

Codicils

Codicils may be used for making any alteration in a Will such as to alter the executors or make changes in legacies, whether by addition or deletion but that is by no means their only use. As a general rule, substantial changes are best achieved by means of a new Will and codicils are more

LEXISNEXIS

The tort of deceit

Deceit—what is it?A deceit occurs when a misrepresentation is made with the express intention of defrauding a party, subsequently causing loss to that party.The elements of a claim in deceit are:•a clear false representation of fact or law•fraud by the maker, in the sense that they knew that the

Related documents:

4 News
View More

Related documents:

4 News
View More